COMBEAU; Cecile

Patent Applications and Registrations

Patent applications and USPTO patent grants for COMBEAU; Cecile.The latest application filed is for "use of anti-ceacam5 immunoconjugates for treating lung cancer".

Company Profile

0.11.14

COMBEAU; Cecile - Paris FR
Combeau; Cecile - Fontenay aux Roses FR
Combeau, Cecile - Chaville FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Anti-ceacam5 Immunoconjugates For Treating Lung Cancer App 20220080053 - ALLARD; Aurore ; et al.	2022-03-17
Anti-cancer compound and pharmaceutical composition containing the same Grant 9,221,817 - Carry , et al. December 29, 2	2015-12-29
Anti-cancer Compound And Pharmaceutical Composition Containing The Same App 20150266877 - CARRY; Jean-Christophe ; et al.	2015-09-24
Anti-cancer compound and pharmaceutical composition containing the same Grant 9,073,917 - Carry , et al. July 7, 2	2015-07-07
Anti-cancer Compound And Pharmaceutical Composition Containing The Same App 20120220621 - Carry; Jean-Christophe ; et al.	2012-08-30
1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them Grant 8,163,768 - Mauger , et al. April 24, 2	2012-04-24
Pyridazinone kinase inhibitors Grant 7,968,546 - Hoelder , et al. June 28, 2	2011-06-28
4-benzimidazol-2-ylpyridazin-3-one derivatives Grant 7,754,713 - Hoelder , et al. July 13, 2	2010-07-13
Novel Pyridazinone Derivatives App 20090130209 - HOELDER; Swen ; et al.	2009-05-21
Pyridazinone derivatives Grant 7,507,734 - Hoelder , et al. March 24, 2	2009-03-24
Novel 4-benzimidazol-2-ylpyridazin-3-one Derivatives App 20090042880 - HOELDER; Swen ; et al.	2009-02-12
4-benzimidazol-2-ylpyridazin-3-one derivatives Grant 7,470,689 - Hoelder , et al. December 30, 2	2008-12-30
Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them Grant 7,462,613 - Holder , et al. December 9, 2	2008-12-09
1,4-Dihydropyridine-Fused Heterocycles, Process for Preparing the Same, Use and Compositions Containing Them App 20080261969 - MAUGER; Jacques ; et al.	2008-10-23
Novel Pyridazinone Derivatives App 20070259870 - HOELDER; Swen ; et al.	2007-11-08
Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives App 20070173503 - Hoelder; Swen ; et al.	2007-07-26
Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology Grant 7,119,115 - Tabart , et al. October 10, 2	2006-10-10
1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof App 20050203170 - Mailliet, Patrick ; et al.	2005-09-15
Compounds derived from oxindoles and their therapeutic application in cancer treatment Grant 6,930,124 - Combeau , et al. August 16, 2	2005-08-16
Novel pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them App 20050026918 - Holder, Swen ; et al.	2005-02-03
Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology App 20040162276 - Tabart, Michel ; et al.	2004-08-19
1,3-diarylprop-2-en-1-ones, Compositions Containing Them And Use Thereof App 20040147584 - Mailliet, Patrick ; et al.	2004-07-29
Compounds derived from oxindoles and their therapeutic application in cancer treatment App 20040082645 - Combeau, Cecile ; et al.	2004-04-29
Novel use of compounds of the chalcones class App 20020143064 - Chiron, Marielle ; et al.	2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.